The consultant pharmacist's role in dialysis: An introduction

Consultant Pharmacist

Volumn 22, Issue 12, 2007, Pages 1035-1044

  Nguyen, Timothy V ^a,b  

^a SAINT PETER'S UNIVERSITY   (United States)

^b Holy Name Hospital   (United States)

Author keywords

Chronic kidney disease; Consultant pharmacist; Dialysis; Hemodialysis; Medication related problem; Peritoneal dialysis

Indexed keywords

ALTERNATIVE MEDICINE; ANEMIA; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONSULTATION; ELECTROLYTE DISTURBANCE; GASTROINTESTINAL DISEASE; GLOMERULUS FILTRATION RATE; HEALTH CARE; HEALTH CARE COST; HEMATOLOGIC DISEASE; HEMODIALYSIS PATIENT; HEPATITIS; HUMAN; HYPOTENSION; INFECTION; INFORMATION PROCESSING; KIDNEY; KIDNEY CLEARANCE; KIDNEY FAILURE; LIFE; MALNUTRITION; MEDICAID; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICARE; NEUROLOGIC DISEASE; PHARMACIST; POPULATION; PREGNANCY DISORDER; RENAL OSTEODYSTROPHY; RENAL REPLACEMENT THERAPY; REVIEW; RISK; SEXUAL DYSFUNCTION; UNITED STATES; UREMIA;

EID: 37349037185     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2007.1035     Document Type: Review

References (47)

1. United States Renal Data System. USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2005.
2. United States Renal Data System. USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004.
3. Anderson RJ, Melikian DM, Gambertoglio JG et al. Prescribing medication in long-term dialysis units. Arch Intern Med 1982;142:1305-8.
4. Shih YT. Effect of insurance on prescription drug use by ESRD beneficiaries. Health Care Finance Rev 1999;20:39-54.
5. Tozawa M, Iseki K, Fukiyama K. Prevalence of hospitalization and prognosis of patients on chronic dialysis. Clin Exp Nephrol 2000;4:236-40.
6. Center for Medicare and Medicaid Services to consider pharmacist's role in dialysis facilities. Federal Register February 4, 2005;70. Proposed rules.
7. New Jersey Department of Health. Re: Subchapter 24. Renal dialysis. 8:43A-24.19 Consultant Pharmacist. New Jersey Register September 6, 2005.
8. Lederer E, Ouseph R. Chronic kidney disease. Am J Kidney Dis 2007;49:162-71.
9. Ifudu O. Care of patients undergoing hemodialysis. N Engl J Med 1998;339:1054-62.
10. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39 suppl 2.
11. National Kidney Foundation. K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006;47:Suppl:1-146 (Updated AJKD 2007;50:3).
12. Klahr S. Chronic renal failure: management. Lancet 1991:338-423.
13. Weizman R, Weizman A, Levi J et al. Sexual dysfunction associated with hyperprolactinemia in males and females undergoing hemodialysis. Psychosom Med 1983;45:259-69.
14. Boomer J, Ritz E, del Pozo E et al. Improved sexual function in male hemodialysis patients on bromocriptine. Lancet 1979;2:496-7.
15. Hou S. Frequency and outcome of pregnancy in women on dialysis. Am J Kidney Dis 1994;23:60-3.
16. Himmelfarb J. Hemodialysis complications. Am J Kidney Dis 2005;45:1122-31.
17. Pastan S, Bailey J. Dialysis therapy. N Engl J Med 1998;338:1428-37.
18. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:3 Suppl 1-147.
19. Levey A, Greene T, Kusek J et al. for the MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol 2000;11:155A.
20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
21. Hemodialysis. Available at http://www.venofer.com/venoferhcp/images/ renal_failure_3.jpg. Accessed March 26, 2007. Adapted with permission.
22. The National Institute of Health, Kidney and Urologic Diseases. Available at http://kidney.niddk.nih.gov/kudiseases/pubs/choosingtreatment/images/ dialysis.gif. Accessed March 26, 2007.
23. National Kidney Foundation. KDOQI clinical practice guidelines for vascular access. Am J Kidney Dis 2006;1 Suppl:176-247.
24. The National Institute of Health, Kidney and Urologic Diseases. Available at http://kidney.niddk.nih.gov/kudiseases/pubs/peritoneal/images/capd.gif. Accessed March 26, 2007.
25. National Kidney Foundation. KDOQI clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006;1 Suppl:2-90.
26. Aronoff GR, Berns JS, Brier ME et al. Drug prescribing in renal failure. Dosing guidelines for adults. 4th ed. Philadelphia, PA: American College of Physicians; 2007.
27. Johnson CA. Dialysis of drugs. Nephrology Pharmacy Associates 2007. Available at www.nephrologypharmacy.com.
28. Manley HJ, Bailie GR, Grabe DW. Comparing medication use in two hemodialysis units against national dialysis databases. Am J Health Syst Pharm 2000;57:902-6.
29. Stand LM, Morley PC, Cipolle RJ et al. Drug-related problems: their structure and function. DICP 1990;24:1093-7.
30. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990;841-5.
31. Enarson TR. Drug-related hospital admissions. Ann Pharmacother 1993;27:832-40.
32. Reprinted from Am J Kidney Dis 2005;45:1105-18. Joy MS, DeHart RM, Gilmartin C et al. Clinical pharmacist as multidisciplinary health care providers in the management of CKD: a joint opinion by the nephrology and ambulatory care practice and research networks of the American College of Clinical Pharmacy. Copyright 2005, with permission from National Kidney Foundation, Inc.
33. Tang I, Vrahnos D, Hatoum H et al. Effectiveness of clinical pharmacist interventions in a hemodialysis unit. Clin Ther 1993;15:459-64.
34. Manley HJ, Carrroll CA. The clinical and economic impact of pharmaceutical care in end-stage renal disease patients. Semin Dial 2002;15:45-9.
35. Johnson JA, Bottman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995;155:1949-56.
36. Murray MD, Callahan CM. Improving medication use for older adults: an integrated research agenda. Ann Intern Med 2003;139:425-9.
37. Tozawa M, Iseki K, Iseki C et al. Analysis of drug prescription in chronic hemodialysis patients. Nephrol Dial Transplant 2002;17:1819-24.
38. Goldberg RM, Mabee J, Chan L et al. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 1996;14:447-50.
39. Schlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int 1993;44:643-53.
40. Ala-Kaila K. Upper gastrointestinal findings in chronic renal failure. Scand J Gastroenterol 1987;22:372-6.
41. Besarab A, Bolton WK, Browne JK et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998;27:584-90.
42. Fishbane S, Maesaka JK. Iron management in end-stage renal disease. Am J Kidney Dis 1997;29:319-33.
43. Ifudu O, Feldman J, Friedman EA. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 1996;334:420-5.
44. Geerlings W, Morris RW, Brunner FP et al. Factors influencing anaemia in dialysis patients: a special survey by the EDTA-ERA Registry. Nephrol Dial Transplant 1993;8:585-9.
45. Grabe DW, Low CL, Bailie GR et al. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol 1997;47:117-21.
46. Cleary DJ, Matzke GR, Alexander AC et al. Medication knowledge and compliance among patients receiving long-term dialysis. Am J Health Syst Pharm 1995;52:1895-900.
47. Cannon KT, Choi MM, Zuniga MA. Potentially inappropriate medication use in the elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother 2006;4:134-43.